European Journal of Cancer
Volume 45, Issue 10 , Pages 1748-1756 , July 2009

A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases

  • Axel Stang

      Affiliations

    • Department of Oncology, Asklepios Hospital Hamburg-Altona, Germany
    • Corresponding Author InformationCorresponding author: Address: Department of Hematology and Oncology, Paul-Ehrlich-Straße 1, 22763 Hamburg, Tel.: +49 (0) 40 18 18 81x1308; fax: +49 (0) 40 18 18 81x4904.
    • ,
  • Roman Fischbach

      Affiliations

    • Department of Radiology, Asklepios Hospital Hamburg-Altona, Germany
    • ,
  • Wolfgang Teichmann

      Affiliations

    • Department of Surgery, Asklepios Hospital Hamburg-Altona, Germany
    • ,
  • Carsten Bokemeyer

      Affiliations

    • Department of Oncology and Hematology with Section Pneumology, University Hospital Hamburg-Eppendorf, Germany
    • ,
  • Dietrich Braumann

      Affiliations

    • Department of Oncology, Asklepios Hospital Hamburg-Altona, Germany

Received 14 February 2009 ,Accepted 12 March 2009.

References 

  1. Seymour MT, Maughan TS, Ledermann JA, et al. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomized controlled trial. Lancet. 2007;370:143–152
  2. Koopmann M, Antonini NF, Douma J, et al. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomized trial. Lancet. 2007;370:135–142
  3. Loupakis F, Masi G, Vasile E, Falcone A. First-line chemotherapy in metastatic colorectal cancer: new approaches and therapeutic algorithms. Always hit hard first?. Curr Opin Oncol. 2008;20:459–465
  4. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13:51–64
  5. Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25:4575–4580
  6. Poston GJ, Adam R, Alberts S, et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol. 2005;23:7125–7134
  7. Adam R, Delvert V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644–658
  8. Ahmad A, Chen SL, Bilchik AJ. Role of repeated hepatectomy in multimodal treatment of hepatic colorectal metastases. Arch Surg. 2007;142:526–532
  9. Stang A, Keles H, von Seydewitz C, et al. Percutanous and intraoperative ultrasonography guided radiofrequency ablation of hepatic tumors. Ultraschall Med. 2007;28:181–188
  10. Garrean S, Hering J, Saied A, Helton S, Espat NJ. Radiofrequency of primary and metastatic liver tumors: a critical review of the literature. Am J Surg. 2008;195:508–520
  11. McGrane S, McSweeeney SE, Maher MM. Which patients will benefit from percutaneous radiofrequency ablation of colorectal cancer metastases ? A critically appaised topic. Abdom Imaging. 2008;33:48–53
  12. Benoist S, Nordlinger B. Radiofrequency ablation in liver tumours. Ann Oncol. 2004;15(Suppl. 4):iv313–iv317
  13. Ruers T, van Coevorden F, Pierie JPJ, et al. Radiofrequency ablation (RFA) combined with chemotherapy for unresectable colorectal liver metastases (CRC LM): interim results of a randomized phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC). J Clin Oncol 2008, ASCO annual meeting proceedings 2008;26:4012 [abstract].
  14. Solbiati L, Livrhagi T, Goldberg SN, et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001;221:159–166
  15. Gillams AR, Lees WR. Radiofrequency ablation of colorectal liver metastases. Abdom Imaging. 2005;30:419–426
  16. Jakobs TF, Hoffmann RT, Trumm C, Reiser MF, Helmberger TK. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients. Anticancer Res. 2006;26:671–680
  17. Amersi FF, Mc-Elrath-Garza A, Ahmad A, et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg. 2006;141:581–588
  18. Abitabile P, Hartl U, Lange J, Maurer CA. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. ESJO. 2007;33:67–71
  19. Siperstein A, Berber E, Ballerm N, Rikesh T. Survival after radiofrequency ablation of colorectal metastases: 10-year experience. Ann Surg. 2007;246:559–567
  20. Sorensen SM, Mortensen FV, Nielsen DT. Radiofrequency of colorectal liver metastases: long-term survival. Acta Radiol. 2007;48:253–258
  21. Veltri A, Sacchetto P, Tosetti I, Pagano E, Fava C, Gandini G. Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol. 2008;31:948–956
  22. Gillams AR, Lees WR. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases. J Vasc Interv Radiol. 2008;17:712–717
  23. Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Brit J Surg. 2003;90:1240–1243
  24. Aloia TA, Vauthey JN, Loyer E, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006;141:460–467
  25. White RR, Avital I, Sofocleous CT, et al. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal metastasis. J Gastrointest Surg. 2007;11:256–263
  26. Park IJ, Kim HC, Yu CS, Kim PN, Won HJ, Kim JC. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol. 2008;15:227–232
  27. Hur H, Ko YT, Min BS, et al. Comparative study of resection and radiofrequency of solitary colorectal metastases. Am J Surg 2008 [ePub before of print].
  28. Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 2003;10:1059–1069
  29. Elias D, Baton O, Sideris L, et al. Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases. J Surg Oncol. 2005;135:657–664
  30. Kornprat P, Jarnagin WR, DeMatteo RP, Fog Y, Blumgart LH, D’Angelica M. Role of intraoperative thermal ablation combined with resection in the treatment of hepatic metastasis from colorectal cancer. Arch Surg. 2007;142:1087–1092
  31. Ogata Y, Uchida S, Hisaka T, et al. Intraoperative thermal ablation therapy for small colorectal metastases to the liver. Hepato-Gastroenterology. 2008;55:550–556
  32. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcome following hepatic resection, radiofrequncy ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–827
  33. Ruers TJM, Joosten JJ, Wiering B, et al. Comparison between local ablative therapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol. 2007;14:1161–1169
  34. Machi J, Oishi AJ, Sumida K, et al. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognosic factors and effectiveness in first- and second-line management. Cancer J. 2006;12:318–326
  35. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242:158–171
  36. Van Duijnhoven FH, Jansen MC, Junggeburt JMC, et al. Factors influencing the local failure rate of radiofrequency ablation of colorectal metastases. Ann Surg Oncol. 2006;13:651–658
  37. Ni Y, Mulier S, Miao Y, Michel L, Marchal G. A review of the general aspect of radiofrequency ablation. Abdom Imaging. 2005;30:381–400
  38. Ahmad A, Chen SL, Kavanagh MA, Allegra DP, Bilchik AJ. Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better?. Am Surg. 2006;72:875–879
  39. Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contradication to liver resection for multiple colorectal metastases?. Ann Surg. 2004;240:1052–1061
  40. Mulier S, Ni Y, Jamart J, Michel L, Marchal G, Ruers T. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?. Ann Surg Oncol. 2008;15:144–157
  41. Curley S. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial?. Ann Surg Oncol. 2008;15:11–13
  42. De Meijer VE, IJzermans JNM. A place for radiofrequency ablation in the treatment of resectable colorectal metastases?. Ann Surg Oncol. 2008;15:2063
  43. Berber E, Pelley R, Siperstein AE. Predictor of survival after radiofrequency thermal ablation of colorectal metastases to the liver: a prospective study. J Clin Oncol. 2005;23:1358–1364
  44. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309–318
  45. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer. 1996;77:1254–1262

PII: S0959-8049(09)00197-X

doi: 10.1016/j.ejca.2009.03.012

European Journal of Cancer
Volume 45, Issue 10 , Pages 1748-1756 , July 2009

Article Tools

* Image Usage & Resolution